Clinical Trials
Successor
Innovative solution unmet clinical needs; Successor Study (Ongoing) SUCCESSOR is a prospective, multicenter registry study in India evaluating the real-world clinical outcomes of the Eluting Coronary Stent System for percutaneous coronary revascularization. It aims to assess the stent system’s effectiveness and safety in challenging cases. The study includes patients aged 18 and above undergoing percutaneous coronary intervention with Encruso, while the primary endpoint is the Target Lesion Failure rate at a 1-year follow-up. Secondary endpoints include various clinical and procedural measures. SUCCESSOR provides valuable insights into the stent system’s real-world performance and its role in percutaneous coronary revascularization.
